Curative Biotechnology, Inc.
CUBT
$0.0115
-$0.0003-2.54%
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 52.64% | -45.47% | |||
| Depreciation & Amortization | 0.00% | 0.00% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.17% | -25.23% | |||
| Operating Income | -12.17% | 25.23% | |||
| Income Before Tax | -10.17% | 7.79% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -10.17% | 7.79% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -10.17% | 7.79% | |||
| EBIT | -12.17% | 25.23% | |||
| EBITDA | -12.19% | 25.26% | |||
| EPS Basic | 0.00% | 4.17% | |||
| Normalized Basic EPS | -- | 6.67% | |||
| EPS Diluted | 0.00% | 4.17% | |||
| Normalized Diluted EPS | -- | 6.67% | |||
| Average Basic Shares Outstanding | -- | 0.03% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
